Webinar on the upcoming call under the Innovative Medicines Initiative (IMI2)
IMI2 will launch its third call on December 12. The call comprises 6 topics stretching from diabetes and vaccine research to quantitative neurobiology. Join EuroCenter, Novo, Lundbeck and the IMI executive office for a webinar on the upcoming call. The webinar takes place 3 December 2014.
- https://ufm.dk/en/newsroom/calendar/2014/webinar-on-the-upcoming-call-under-the-innovative-medicines-initiative-imi2
- Webinar on the upcoming call under the Innovative Medicines Initiative (IMI2)
- 2014-12-03T15:45:00+01:00
- 2014-12-03T17:00:00+01:00
- IMI2 will launch its third call on December 12. The call comprises 6 topics stretching from diabetes and vaccine research to quantitative neurobiology. Join EuroCenter, Novo, Lundbeck and the IMI executive office for a webinar on the upcoming call. The webinar takes place 3 December 2014.
- Time and place
- When December 03, 2014 from 03:45 PM to 05:00 PM
Attendees
The webinar is relevant for:
-
Academic institutions
-
Research organisations
-
Small & medium-sized enterprises (SMEs)
-
Mid-sized enterprises (≤ 500M)
-
Non-profit patient organisations
-
Non-profit public bodies and intergovernmental organisations including specialised agencies.
The third call under the innovative medicines initiative (IMI2) comprises the following 6 topics:
- Remote assessment of disease and relapse (RADAR), topic 1: central nervous system (CNS)
- Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
- Linking clinical neuropsychiatry and quantitative neurobiology
- The consistency approach to quality control in vaccine manufacture
- Pertussis vaccination research
- Knowledge Repository to enable patient focused medicine development
Content
| Draft agenda |
|---|
| IMI2 introduction and rules of participation Kim L. Kryger, EuroCenter, Danish Agency for Science Technology and Innovation |
| IMI - the industry perspective Jørgen Dirach, Novo & Ejner K. Moltzen, Lundbeck |
| Introduction to topics 1, 2 and 3 and Q & A appointed researchers from Novo and Lundbeck |
| Introduction to topics 4-6 and Q &A Elisabetta Vaudano, Principal Scientific Manager, IMI Executive Office |
|
Closing remarks |
Organiser
The event is organised the Danish Agency for Science, Technology and Innovation and facilitated by Biopeople, Denmark’s Life Science Cluster.
Registration
Contact
Kim L. Kryger
phone: +45 7231 8288
e-mail: klk@fi.dk
Document Actions
last modified
November 27, 2014